Navigation Links
Height of ignorance in people!

People are very ignorant when it comes to their health. A startling study shows that people are oblivious to the harmful effects of painkillers. Findings signify need for patient education on complications of misusing painkillers.//

According to a study supported by the American Gastroenterological Association (AGA), over-the-counter and prescription painkillers are often used inappropriately and there is an alarming number of people who are ignorant to the potential side effects. Despite the widespread use of store-bought and prescription painkillers, also known as non-steroidal anti-inflammatory drugs (NSAIDs), this is the first study to look at the characteristics of the population who frequently uses painkillers and their attitudes and behaviours. The study is published in the November issue of the Journal of Rheumatology.

'This study shows just how common these medications are used and highlights the lack of insight into their potential dangers,' said C. Mel Wilcox, MD, lead study author from the University of Alabama at Birmingham. "The findings paint a clear picture of the need for patient and physician education efforts and interventions to help prevent unnecessary complications from painkillers.'

A nationwide survey of adult households in the United States was commissioned to determine perceptions of NSAIDs users on the effectiveness of the drugs and their safety, and knowledge regarding side effects and medical complications associated with over-the-counter and prescription painkillers. NSAID users were defined in the study as those people who used prescription or over-the-counter painkillers on at least two occasions in the year prior to the survey for at least five consecutive days at a time.

Of the 807 people surveyed who used NSAIDs, 54 percent were not aware of the potential side effects of these drugs and 18 percent has previously experienced side effects. Those who used over-the-counter painkillers commonl y experienced side effects such as stomach pain, internal bleeding and ulcers. Moreover, nearly 30 percent of these people did not consider themselves at risk for any side effects associated with painkiller use. Similar numbers of people who exclusively used prescription painkillers were unaware of their risks and experienced complications.

Everyday more than 36 million people take over-the-counter and prescription NSAIDs for pain relief, headaches and arthritis, with nearly 25 percent exceeding the recommended dosage. Although long-term use of NSAIDs in high doses can provide great benefit in terms of anti-inflammatory effects, pain relief and cardio protective effects, there is an increased risk of gastrointestinal complications ranging from stomach pain to ulcers, haemorrhage, and severe and potentially deadly gastrointestinal problems. Each year, the side effects of long-term NSAID use cause nearly 103,000 hospitalizations and 16,500 deaths by some estimates.

In 2003, the AGA launched the R.E.D.U.C.E. (Risk Education to Decrease Ulcer Complications and Their Effects from NSAIDs) Campaign to help explain the potentially harmful effects of NSAIDs and how Americans can lower their risk for serious gastrointestinal problems. The findings of this study make programs like the R.E.D.U.C.E. campaign relevant and useful to the population of people who use painkillers regularly and the physicians who treat them. Pfizer provided funding for the R.E.D.U.C.E. campaign.

Source: American Gastroenterological Association
'"/>




Related medicine news :

1. Suppressing A Girls Height In Adolescence Could Lead to Fertility Problems
2. Airlines Pilot At Heightened Risk Of Having Cataracts
3. A New Technique For Prediction Of Adult Height
4. Lifespan And Height Interlinked With Juvenile Diseases.
5. Height Loss Determines Risk Of Vertebral Fractures And Bone Disease
6. Using Herbal Products Heightens Substance Abuse Risk in Teens
7. Using Hormone Therapy to Shape Children’s Height to Social Norm
8. “Erectile Dysfunction” Drugs Heighten Natural Anti-Cancer Activiy
9. Abnormal Height Loss May Forecast Mortality in Men
10. Height of Liberation – Lesbians, No Less in Producing Babies (read Daughters
11. Breast cancer ignorance revealed
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... , ... 21 Middle East and South Asia Leaders Selected as Eisenhower Fellows ... and civil society in 11 countries across the Middle East and South Asia to ... exchange of knowledge and ideas with the leading minds in their fields. , ...
(Date:6/23/2017)... ... , ... PureLife Dental is pleased to announce that California Dental Association (CDA) ... of the amalgam separator endorsement, all CDA members may purchase an ECO II amalgam ... value. This partnership between PureLife and CDA is especially timely as it coincides with ...
(Date:6/23/2017)... , ... June 23, 2017 , ... American Farmer, will ... series, which is slated to air fourth quarter 2017. American Farmer airs Tuesdays at ... Hansen, a Danish pharmacist, founded Chr. Hansen in Denmark in 1874 after a groundbreaking ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... and related services to families and business owners in and around Lackawanna County, ... benefit senior citizens in the area. , Meals on Wheels of NEPA provides ...
(Date:6/23/2017)... ... June 23, 2017 , ... All-Star Insurance, a family managed agency that ... eastern Texas, is announcing the launch of a new charity drive to benefit women ... the United States reveal that an estimated 252, 710 new cases of invasive or ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 2017  Less than a month ago, amateur hackers ... companies, including hospital networks, in over 150 countries. ... the largest online extortion attempts ever recorded. With the ... is imperative that providers understand where the risks lie, ... — and many other very real cyber threats.  ...
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
Breaking Medicine Technology: